The biobank equipment market size has grown strongly in recent years. It will grow from $4.18 billion in 2025 to $4.58 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to growing biobanking initiatives, rising clinical research activity, manual sample handling inefficiencies, need for traceable sample storage, increasing genomics research.
The biobank equipment market size is expected to see strong growth in the next few years. It will grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to adoption of automated and hybrid biobanking systems, integration of ai and cloud analytics, expansion of regenerative medicine research, rising demand for cell and dna storage, technological innovation in cryogenic systems. Major trends in the forecast period include AI-enhanced sample management systems, iot-enabled cryogenic monitoring, automated biobanking platforms, cloud-based data tracking systems, high-throughput sample storage solutions.
The rising demand for personalized medicine is anticipated to boost the growth of the biobank equipment market in the coming years. Personalized medicine is a medical approach that tailors treatment and prevention strategies according to individual variations in genes, environments, and lifestyles. The growing adoption of personalized medicine is supported by advancements in genomic sequencing technologies and data analytics, enabling healthcare providers to create more precise diagnostic tools and targeted therapies for specific patients. Biobank equipment plays a vital role in personalized medicine by efficiently preserving and managing biological samples containing essential genetic and molecular information, allowing researchers to study individual differences, identify biomarkers, and develop patient-specific therapies. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. Therefore, the rising demand for personalized medicine is driving the expansion of the biobank equipment market.
Leading companies in the biobank equipment market are focusing on introducing next-generation automated storage systems to enhance sample preservation and meet the increasing demand for personalized medicine. Automated storage systems are advanced solutions that manage, store, and retrieve biological samples with minimal human intervention, ensuring accurate handling, high security, and reliable preservation through the use of robotics and digital controls to maintain sample integrity and traceability. For instance, in February 2024, Azenta Inc., a US-based provider of life sciences solutions, launched the BioArc Ultra, a next-generation automated ultracold storage solution offering high-density, eco-friendly sample management for biorepositories. It enables efficient automated sample handling at -80°C using an innovative refrigeration system with zero ozone depletion potential and zero global warming potential. The BioArc Ultra significantly lowers power usage and space requirements compared to traditional systems, improving energy efficiency and sustainability in large-scale biological sample storage operations.
In November 2024, Standex International Corporation, a US-based industrial growth company, acquired Custom Biogenic Systems for $6.2 million. This acquisition aims to strengthen Standex International’s Scientific business segment by incorporating Custom Biogenic Systems’ advanced cryogenic storage and refrigeration technologies. The acquisition broadens Standex’s presence in the pharmaceutical and biobank markets while expanding its technology portfolio with liquid nitrogen and controlled-rate freezer systems. Custom Biogenic Systems is a US-based manufacturer of biobank equipment.
Major companies operating in the biobank equipment market are Thermo Fisher Scientific Inc., Merck KGaA Darmstadt Germany, Becton Dickinson and Company, Agilent Technologies Inc., Revvity Inc., PHC Holdings Corporation, QIAGEN N.V., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, Hamilton Company, Azenta Life Sciences Inc., Promega Corporation, BioLife Solutions Inc., Standard BioTools Inc., SPT Labtech Ltd, LabVantage Solutions Inc., Izon Science Limited, askion GmbH, Custom Biogenic Systems Inc., Zhongke Meiling Cryogenics Co. Ltd.
North America was the largest region in the biobank equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biobank equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biobank equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs on imported cryogenic freezers, alarm systems, and automated storage equipment have raised costs for biobanks, research institutes, and hospitals, particularly in North America and Europe. Products such as automated biobanking systems and modular storage units are most affected. On the positive side, tariffs have encouraged local production, innovation in cost-effective storage solutions, and accelerated adoption of digital monitoring and data management technologies in regional biobanking operations.
The biobank equipment market research report is one of a series of new reports that provides biobank equipment market statistics, including biobank equipment industry global market size, regional shares, competitors with a biobank equipment market share, detailed biobank equipment market segments, market trends and opportunities, and any further data you may need to thrive in the biobank equipment industry. This biobank equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biobank equipment refers to specialized tools and systems designed for the collection, processing, and preservation of biological samples under controlled conditions to maintain their long-term integrity. It enables accurate and efficient sample management, ensuring high-quality samples for future research and analysis. Biobank equipment improves data reliability and traceability, supporting consistent and reproducible scientific results.
The primary product types of biobank equipment include cryogenic storage systems and alarm and monitoring systems. Cryogenic storage systems are specialized units used to preserve biological samples at extremely low temperatures, ensuring their long-term stability and integrity. The sample types include blood products, human tissue, umbilical cord blood stem cells, deoxyribonucleic acid (DNA), and cell lines, and the storage systems include automated biobanking systems, manual biobanking systems, hybrid biobanking systems, modular storage systems, and compact storage systems. It is utilized in various applications such as regenerative medicine, life science research, clinical research, and others and is employed by multiple end-users including biobanks and biorepositories, pharmaceutical and biotechnology companies, academic and research institutions, and hospital and diagnostic centers.
The biobank equipment market consists of sales of sample storage freezers, centrifuges, biospecimen tracking systems, and temperature monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The biobank equipment market size is expected to see strong growth in the next few years. It will grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to adoption of automated and hybrid biobanking systems, integration of ai and cloud analytics, expansion of regenerative medicine research, rising demand for cell and dna storage, technological innovation in cryogenic systems. Major trends in the forecast period include AI-enhanced sample management systems, iot-enabled cryogenic monitoring, automated biobanking platforms, cloud-based data tracking systems, high-throughput sample storage solutions.
The rising demand for personalized medicine is anticipated to boost the growth of the biobank equipment market in the coming years. Personalized medicine is a medical approach that tailors treatment and prevention strategies according to individual variations in genes, environments, and lifestyles. The growing adoption of personalized medicine is supported by advancements in genomic sequencing technologies and data analytics, enabling healthcare providers to create more precise diagnostic tools and targeted therapies for specific patients. Biobank equipment plays a vital role in personalized medicine by efficiently preserving and managing biological samples containing essential genetic and molecular information, allowing researchers to study individual differences, identify biomarkers, and develop patient-specific therapies. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. Therefore, the rising demand for personalized medicine is driving the expansion of the biobank equipment market.
Leading companies in the biobank equipment market are focusing on introducing next-generation automated storage systems to enhance sample preservation and meet the increasing demand for personalized medicine. Automated storage systems are advanced solutions that manage, store, and retrieve biological samples with minimal human intervention, ensuring accurate handling, high security, and reliable preservation through the use of robotics and digital controls to maintain sample integrity and traceability. For instance, in February 2024, Azenta Inc., a US-based provider of life sciences solutions, launched the BioArc Ultra, a next-generation automated ultracold storage solution offering high-density, eco-friendly sample management for biorepositories. It enables efficient automated sample handling at -80°C using an innovative refrigeration system with zero ozone depletion potential and zero global warming potential. The BioArc Ultra significantly lowers power usage and space requirements compared to traditional systems, improving energy efficiency and sustainability in large-scale biological sample storage operations.
In November 2024, Standex International Corporation, a US-based industrial growth company, acquired Custom Biogenic Systems for $6.2 million. This acquisition aims to strengthen Standex International’s Scientific business segment by incorporating Custom Biogenic Systems’ advanced cryogenic storage and refrigeration technologies. The acquisition broadens Standex’s presence in the pharmaceutical and biobank markets while expanding its technology portfolio with liquid nitrogen and controlled-rate freezer systems. Custom Biogenic Systems is a US-based manufacturer of biobank equipment.
Major companies operating in the biobank equipment market are Thermo Fisher Scientific Inc., Merck KGaA Darmstadt Germany, Becton Dickinson and Company, Agilent Technologies Inc., Revvity Inc., PHC Holdings Corporation, QIAGEN N.V., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, Hamilton Company, Azenta Life Sciences Inc., Promega Corporation, BioLife Solutions Inc., Standard BioTools Inc., SPT Labtech Ltd, LabVantage Solutions Inc., Izon Science Limited, askion GmbH, Custom Biogenic Systems Inc., Zhongke Meiling Cryogenics Co. Ltd.
North America was the largest region in the biobank equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biobank equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biobank equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs on imported cryogenic freezers, alarm systems, and automated storage equipment have raised costs for biobanks, research institutes, and hospitals, particularly in North America and Europe. Products such as automated biobanking systems and modular storage units are most affected. On the positive side, tariffs have encouraged local production, innovation in cost-effective storage solutions, and accelerated adoption of digital monitoring and data management technologies in regional biobanking operations.
The biobank equipment market research report is one of a series of new reports that provides biobank equipment market statistics, including biobank equipment industry global market size, regional shares, competitors with a biobank equipment market share, detailed biobank equipment market segments, market trends and opportunities, and any further data you may need to thrive in the biobank equipment industry. This biobank equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biobank equipment refers to specialized tools and systems designed for the collection, processing, and preservation of biological samples under controlled conditions to maintain their long-term integrity. It enables accurate and efficient sample management, ensuring high-quality samples for future research and analysis. Biobank equipment improves data reliability and traceability, supporting consistent and reproducible scientific results.
The primary product types of biobank equipment include cryogenic storage systems and alarm and monitoring systems. Cryogenic storage systems are specialized units used to preserve biological samples at extremely low temperatures, ensuring their long-term stability and integrity. The sample types include blood products, human tissue, umbilical cord blood stem cells, deoxyribonucleic acid (DNA), and cell lines, and the storage systems include automated biobanking systems, manual biobanking systems, hybrid biobanking systems, modular storage systems, and compact storage systems. It is utilized in various applications such as regenerative medicine, life science research, clinical research, and others and is employed by multiple end-users including biobanks and biorepositories, pharmaceutical and biotechnology companies, academic and research institutions, and hospital and diagnostic centers.
The biobank equipment market consists of sales of sample storage freezers, centrifuges, biospecimen tracking systems, and temperature monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Biobank Equipment Market Characteristics
3. Biobank Equipment Market Supply Chain Analysis
4. Global Biobank Equipment Market Trends and Strategies
5. Biobank Equipment Market Analysis of End Use Industries
7. Global Biobank Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Biobank Equipment Total Addressable Market (TAM) Analysis for the Market
9. Biobank Equipment Market Segmentation
10. Biobank Equipment Market Regional and Country Analysis
11. Asia-Pacific Biobank Equipment Market
12. China Biobank Equipment Market
13. India Biobank Equipment Market
14. Japan Biobank Equipment Market
15. Australia Biobank Equipment Market
16. Indonesia Biobank Equipment Market
17. South Korea Biobank Equipment Market
18. Taiwan Biobank Equipment Market
19. South East Asia Biobank Equipment Market
20. Western Europe Biobank Equipment Market
21. UK Biobank Equipment Market
22. Germany Biobank Equipment Market
23. France Biobank Equipment Market
24. Italy Biobank Equipment Market
25. Spain Biobank Equipment Market
26. Eastern Europe Biobank Equipment Market
27. Russia Biobank Equipment Market
28. North America Biobank Equipment Market
29. USA Biobank Equipment Market
30. Canada Biobank Equipment Market
31. South America Biobank Equipment Market
32. Brazil Biobank Equipment Market
33. Middle East Biobank Equipment Market
34. Africa Biobank Equipment Market
36. Biobank Equipment Market Competitive Landscape and Company Profiles
37. Biobank Equipment Market Other Major and Innovative Companies
40. Biobank Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Biobank Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses biobank equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biobank equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biobank equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Cryogenic Storage Systems; Alarm And Monitoring Systems2) By Sample Type: Blood Products; Human Tissue; Umbilical Cord Blood Stem Cells; Deoxyribonucleic Acid (DNA); Cell Lines
3) By Storage System: Automated Biobanking Systems; Manual Biobanking Systems; Hybrid Biobanking Systems; Modular Storage Systems; Compact Storage Systems
4) By Applications: Regenerative Medicine; Life Science Research; Clinical Research; Other Applications
5) By End-User: Biobanks And Biorepositories; Pharma And Biotech Companies; Academic And Research Institutes; Hospital And Diagnostic Centers
Subsegments:
1) By Cryogenic Storage Systems: Cryogenic Storage Systems; Liquid Nitrogen Freezers; Ultra-Low Temperature Freezers; Cryogenic Vials; Cryogenic Storage Tanks2) By Alarm And Monitoring Systems: Alarm And Monitoring Systems; Temperature Monitoring Systems; Humidity Monitoring Systems; Carbon Dioxide (CO2) Monitoring Systems; Remote Alarm Systems; Data Logging Systems
Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA Darmstadt Germany; Becton Dickinson and Company; Agilent Technologies Inc.; Revvity Inc.; PHC Holdings Corporation; QIAGEN N.V.; Eppendorf SE; Tecan Group Ltd.; Bio-Techne Corporation; Hamilton Company; Azenta Life Sciences Inc.; Promega Corporation; BioLife Solutions Inc.; Standard BioTools Inc.; SPT Labtech Ltd; LabVantage Solutions Inc.; Izon Science Limited; askion GmbH; Custom Biogenic Systems Inc.; Zhongke Meiling Cryogenics Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Biobank Equipment market report include:- Thermo Fisher Scientific Inc.
- Merck KGaA Darmstadt Germany
- Becton Dickinson and Company
- Agilent Technologies Inc.
- Revvity Inc.
- PHC Holdings Corporation
- QIAGEN N.V.
- Eppendorf SE
- Tecan Group Ltd.
- Bio-Techne Corporation
- Hamilton Company
- Azenta Life Sciences Inc.
- Promega Corporation
- BioLife Solutions Inc.
- Standard BioTools Inc.
- SPT Labtech Ltd
- LabVantage Solutions Inc.
- Izon Science Limited
- askion GmbH
- Custom Biogenic Systems Inc.
- Zhongke Meiling Cryogenics Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.58 Billion |
| Forecasted Market Value ( USD | $ 6.5 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
